Home   >  

Classified by application

All Products

Signaling Pathways

Research Areas

Nature products

Antibodies

Peptides

Catalysts

Impurities

Intermediate

Raw Materials

Epigenetics

Chemical Structure Cat. No. Product Name CAS No.
QL-1200186 Chemical Structure
BCP49631 QL-1200186 2848664-42-4
QL-1200186 is an orally active and selective TYK2 inhibitor.
MS023 dihydrochloride Chemical Structure
BCP49591 MS023 dihydrochloride 1992047-64-9
MS023 dihydrochloride is a potent, selective, and cell-active inhibitor of human type I protein arginine methyltransferases (PRMTs) inhibitor, with IC50s of 30, 119, 83, 4 and 5 nM for PRMT1, PRMT3, PRMT4, PRMT6, and PRMT8, respectively.
Olpasiran Chemical Structure
BCP49527 Olpasiran 2225856-03-9
Olpasiran is a small interfering RNA that reduces lipoprotein(a) synthesis in the liver.
ARX-788 Chemical Structure
BCP49232 ARX-788 2636710-07-9
ARX788 is a next-generation, site-specific anti-HER2 ADC that utilizes a unique nonnatural amino acid–enabled conjugation technology and a noncleavable Amberstatin (AS269) drug-linker to generate a homogeneous ADC with a drug-to-antibody ratio of 1.9.
Tinengotinib Chemical Structure
BCP49223 Tinengotinib 2230490-29-4
Tinengotinib is an antineoplastic tyrosine kinase inhibitor.Tinengotinib is the modulator of one or more protein kinases such as Aurora kinase and VEGFR kinase.
Pociredir Chemical Structure
BCP49202 Pociredir 2490674-02-5
Pociredir is an embryonic ectoderm development (EED) protein inhibitor. Pociredir can be used for the research of inflammatory or hemoglobinopathies, such as sickle cell disease.
PXL-770 Chemical Structure
BCP49199 PXL-770 1523493-53-9
PXL 770 is an orally active, small molecule, selective and direct AMP-activated protein kinase (AMPK) activator.
TNG908 Chemical Structure
BCP49197 TNG908 2760481-53-4
TNG908 is a MTAP-cooperative PRMT5 inhibitor that can pass through the blood-brain barrier.
Filgotinib maleate Chemical Structure
BCP49095 Filgotinib maleate 1802998-75-9
Filgotinib maleate is a potent and selective JAK1 inhibitor under investigation for the treatment of rheumatoid arthritis (RA) and Crohn's disease.
PFI-4 Chemical Structure
BCP23818 PFI-4 900305-37-5
PFI-4 is a potent and highly selective BRPF1 Bromodomain (BRPF1B) inhibitor, with an IC50 of 172 nM. PFI-4 can be used to explore the functional mechanisms of the HBO1/BRPF1 complex and to study bone loss and osteolytic malignant bone lesions.
123下一页末页共 708 条记录 1 / 71 页 
0086-13720134139